▪  610.800.0155

GMP Testing Laboratory · Allentown, PA | Build Your Audit Package

Scientist reviewing trend data for water system

Water System Excursions Early Warning Signs

A laboratory technician in a white coat and gloves analyzing data on a tablet, with a graph displayed on the screen, in a sterile industrial environment with stainless steel equipment.

Water System Excursions Rarely Begin With One Bad Result

Before a water system fails, it often whispers.

A pharmaceutical water system rarely moves from a stable state of control to a significant excursion without giving some indication that conditions are changing.

The warning may be subtle: a gradual increase in microbial counts, recurring recovery at the same point of use, a change in the types of organisms identified, or results that remain within limits but begin moving away from their historical baseline. Individually, each result may be acceptable. Together, they may tell a different story.

A passing result confirms that one sample met its acceptance criteria. It does not necessarily confirm that the entire water system remains healthy.

Before a Water System Fails, It Often Whispers

Pharmaceutical water systems are dynamic. Source water quality, temperature, flow, system use, sanitization effectiveness, maintenance activities, and sampling practices can all affect system performance.

Potential early indicators of a developing problem may include:

  • Increasing microbial counts that remain below the action level
  • Repeated recovery from the same sampling location
  • Recurring or changing microbial species
  • Increased variability between sampling events
  • A shorter period of control following sanitization
  • Changes in Total Organic Carbon or conductivity trends
  • Results that differ from the same season in previous years
  • Increasing differences between the storage tank, return loop, and points of use
  • Recoveries following periods of low use, shutdown, or maintenance

None of these observations automatically proves that the water system is out of control. They should, however, prompt someone to ask why the pattern is changing.

Compliance Is More Than Pass or Fail

Compendial specifications and established alert and action levels are essential, but reviewing water results only as pass or fail can allow meaningful trends to go unnoticed.

Consider a water-system location that historically produces results of less than 1 CFU per sample. If several consecutive results increase to 5, 8, and 12 CFU, each result may still be below the established action level. Yet the upward movement could represent a meaningful departure from normal system performance.

Waiting until the result exceeds the action level may mean waiting until an emerging condition has become an established problem.

USP <1231>, Water for Pharmaceutical Purposes, emphasizes monitoring and controlling pharmaceutical water systems based on their normal microbial performance. Alert and action levels should help identify adverse trends and should not be treated simply as interchangeable numerical specifications. USP Water System FAQ

Organism Identity Adds Context

A colony count provides only part of the information needed to evaluate a microbial result. The organism’s identity, location, frequency, and history can be equally important.

The repeated recovery of the same organism may suggest a persistent source or harborage location. Recovery of an objectionable organism may warrant additional attention even when the total count is low. A shift from organisms commonly associated with the surrounding environment to water-associated Gram-negative bacteria may change the risk assessment.

Questions to consider include:

  • Has this organism been recovered from the system before?
  • Is it appearing at one location or throughout the distribution loop?
  • Was it recovered before or after sanitization?
  • Is it associated with biofilm formation or water environments?
  • Could it affect the product, process, or intended use of the water?
  • Has the same organism appeared in environmental or product samples?
  • Does its recurrence suggest that the investigation should extend beyond the affected sample point?

Microbial identification turns an isolated number into information that can support a more scientifically meaningful investigation.

Look Beyond the Sample Point

When an atypical or out-of-limit result occurs, the affected sample point is an appropriate place to begin, but it should not automatically be treated as the source.

A comprehensive investigation may consider:

  • Source water quality and seasonal variability
  • Pretreatment and purification performance
  • Storage tank conditions
  • Distribution-loop flow and temperature
  • Dead legs, low-use outlets, hoses, valves, and other potential harborage areas
  • Sanitization frequency and effectiveness
  • Recent maintenance or system changes
  • Stagnation during shutdowns or periods of reduced production
  • Sample collection technique
  • Sample containers, storage, transport, and hold time
  • Laboratory method suitability and recovery conditions
  • Related microbial, TOC, conductivity, and endotoxin data

FDA has specifically noted that seasonal changes in temperature and source-water flora may affect microbial content and that monitoring should be frequent enough to account for these variations. FDA: Water for Pharmaceutical Use

Sampling Can Create—or Conceal—a Problem

Not every unexpected result originates in the water system. Poor sampling technique, an inadequately sanitized outlet, inappropriate sample handling, or delayed analysis can introduce contamination or distort the result.

At the same time, repeatedly dismissing an atypical result as “sampling error” without supporting evidence can conceal a developing system problem.

A defensible investigation should evaluate both possibilities. This includes reviewing how the sample was collected, whether the outlet was flushed or disinfected appropriately, the container used, sample temperature, transportation conditions, time to analysis, and analyst observations.

Resampling may provide useful additional information, but a passing resample does not invalidate the original result. Both results should be evaluated within the broader system history.

Trending Turns Results Into Knowledge

Effective trending connects individual data points and makes changes easier to recognize. Data may be reviewed by:

  • Sampling location
  • Water-system component
  • Organism identity
  • Test method
  • Sanitization cycle
  • Time since sanitization
  • Season
  • Production schedule
  • Alert or action-level frequency
  • Maintenance or change-control history

The goal is not to generate more charts. It is to determine whether the system continues to perform as expected and identify meaningful changes early enough to respond.

Listen Before the System Has to Shout

A strong pharmaceutical water-monitoring program does more than identify failures. It provides evidence that the system remains in control and creates opportunities to act before product quality or operations are affected.

One result tells you what was recovered from one sample at one moment.

A trend tells you what the water system may be becoming.

At PlumGXP, we support pharmaceutical water-system qualification and routine monitoring through onsite sampling, microbial enumeration, microbial identification, Total Organic Carbon, conductivity, pH, and bacterial endotoxin testing. Our team can also assist with data review, trending, and investigation support.

Is your water-system program reviewing results—or listening to what the system is telling you?

See how PlumGXP can help.


Previous post